Hims & Hers Health HIMS
NYSE · Services-Offices & Clinics Of Doctors Of Medicine · $4.4BData provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
1 story has a settled next close so far (1 on the Wire). The record starts speaking at three.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via DatabentoOperating leverage — margins
| Line Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY Δ | 4Y CAGR | Trend |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | $271.9M | $526.9M | $872.0M | $1.5B | $2.3B | +59.0% | +71.4% | |
| Cost of Revenue (COGS) | $67.4M | $118.2M | $157.1M | $303.4M | $614.3M | +102.5% | +73.8% | |
| Gross Profit | $204.5M | $408.7M | $714.9M | $1.2B | $1.7B | +47.8% | +70.6% | |
| Selling, General & Admin (SG&A) | $183.6M | — | — | — | $183.6M | — | +0.0% | |
| Total Operating Expenses | $319.5M | $477.4M | $744.4M | $1.1B | $1.6B | +46.5% | +50.2% | |
| Operating Income (EBIT) | $-115.0M | $-68.7M | $-29.5M | $61.9M | $105.6M | +70.6% | — | |
| Interest Expense | $0 | — | — | — | $0 | — | — | |
| Income Tax Expense | $-3.1M | $-31,000 | $2.0M | $-54.3M | $-4.4M | +91.8% | — | |
| GAAP Net Income | $-107.7M | $-65.7M | $-23.5M | $126.0M | $128.4M | +1.8% | — | |
| Diluted EPS | $-0.58 | $-0.32 | $-0.11 | $0.53 | $0.51 | −3.8% | — | |
| Diluted Shares | 186.8M | 204.5M | 209.3M | 236.8M | 258.2M | +9.0% | +8.4% | |
| Balance Sheet | ||||||||
| Cash & Equivalents | $72.6M | $47.6M | $97.5M | $221.4M | $228.6M | +3.2% | +33.2% | |
| Inventory | $13.6M | $21.6M | $22.5M | $64.4M | $80.1M | +24.4% | +55.9% | |
| Total Current Assets | $269.9M | $216.6M | $265.1M | $395.8M | $767.6M | +93.9% | +29.9% | |
| Total Assets | $420.6M | $366.3M | $441.2M | $707.5M | $2.2B | +204.5% | +50.4% | |
| Total Current Liabilities | $79.2M | $47.9M | $88.5M | $221.4M | $404.4M | +82.7% | +50.3% | |
| Total Debt (Short + Long Term) | $0 | $0 | $0 | $0 | $0 | — | — | |
| Total Liabilities | $86.0M | $54.6M | $97.2M | $230.8M | $1.6B | +599.1% | +108.2% | |
| Stockholders' Equity | $334.6M | $311.7M | $344.0M | $476.7M | $540.9M | +13.5% | +12.8% | |
| Net Cash / (Net Debt) | $72.6M | $47.6M | $97.5M | $221.4M | $228.6M | +3.2% | +33.2% | |
| Invested Capital | $262.0M | $264.1M | $246.5M | $255.3M | $312.3M | +22.3% | +4.5% | |
| Cash Flow & Capital Allocation | ||||||||
| Operating Cash Flow (OCF) | $-34.4M | $-26.5M | $73.5M | $251.1M | $300.0M | +19.5% | — | |
| Depreciation & Amortization (D&A) | $4.1M | $7.5M | $9.5M | $17.1M | $54.5M | +218.9% | +91.2% | |
| Stock-Based Compensation (SBC) | $67.2M | $42.8M | $66.1M | $92.3M | $135.2M | +46.5% | +19.1% | |
| Share Repurchases (Buybacks) | $0 | $0 | $2.0M | $83.0M | $90.0M | +8.3% | — | |
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.